Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Nanomedicine & Nanotechnology Open Access Research Article 5 min read

Solution-Processed Chiral Perovskites for Biomedical Applications

Gull S and Ullah F*
* Corresponding author
ISSN: 2574-187X  10.23880/nnoa-16000349  Received: October 31, 2025  Published: November 10, 2025
  views
 10 references
PDF
Keywords
Chiral Perovskites Semiconductors Nanomaterials
Abstract

Chirality (conformational arrangements) is a geometric property describing objects that are non-superimposable on their mirror images, a phenomenon known as broken mirror symmetry. In molecular science, this results in two distinct mirror-image forms called enantiomers, often labelled as R/S or L/D, which are right-handed and left-handed versions of the same molecule. The functional significance of chirality arises from how these specific “handednesses” interact at chiral interfaces or with chiral light, enabling highly precise molecular analysis and offering great potential for biomedical applications.

Editorial

Chirality (conformational arrangements) is a geometric property describing objects that are non-superimposable on their mirror images, a phenomenon known as broken mirror symmetry. In molecular science, this results in two distinct mirror-image forms called enantiomers, often labelled as R/S or L/D, which are right-handed and left-handed versions of the same molecule. The functional significance of chirality arises from how these specific “handednesses” interact at chiral interfaces or with chiral light, enabling highly precise molecular analysis and offering great potential for biomedical applications [1].

Chiral Perovskites; Semiconductors; Nanomaterials

Abbreviations

CD: Circular Dichroism; CPL: Circularly Polarized Luminescence; NLO: Nonlinear Optical; CISS: Chiral-Induced Spin Selectivity.

Introduction

Chirality is a ubiquitous property of nature and is essential to organic systems such as DNA, RNA, proteins, and saccharides. Notably, these biological systems are homochiral, meaning they exist in only one enantiomeric form, a property critical to sustaining life. Naturally, often only one enantiomer (configuration) is biologically active or beneficial, while its mirror image can be inert or even harmful. A stark example is found in Parkinson’s disease treatment: L-dopamine provides therapeutic relief, whereas its counterpart, D-dopamine, can lead to toxic side effects like mitochondrial dysfunction and weight loss. This underscores the urgent need to develop synthetic chiral materials. Consequently, there is a strong drive to engineer inorganic chiral nanostructures. These nanomaterials offer significant advantages, including a high surface-to-volume ratio for enhanced interactions, superior structural stability, tunable optical, electrical, and magnetic properties, resilience in harsh environmental conditions, and straightforward synthesis [2].

Recent advances have led to asymmetric, engineered perovskites by incorporating chiral molecular organics into their frameworks, expanding their potential beyond displays into medicine. This engineered asymmetry directly yields unique chiroptical and electronic phenomena: circular dichroism (CD), circularly polarized luminescence (CPL), nonlinear optical (NLO) responses, and the chiral-induced spin selectivity (CISS) effect. Given the fundamental role of chiroptical effects in biological processes, the ability to modulate a perovskite’s key features via chiral ligand integration becomes a powerful tool, thus facilitating their customization for a spectrum of cutting-edge applications. Despite the established role of perovskite-based materials technologies in bioimaging and detection [3, 4], the landscape of chiral perovskites and their considerable potential for advanced biology remains markedly underexplored.

Various methodologies enable the integration of chirality into perovskite architectures. These include:

  • a chiral ligand-induced strategy, where chiral organic molecules are incorporated as A-site cations a comparatively straightforward approach [5]
  • inducing chiral distortion on perovskite surfaces using adsorbed chiral molecules [6]
  • achieving enantiomer enrichment via chiral dislocations prompted by organic molecules Zhong WH, et al. [7] and
  • a final mechanism involving chirality transfer through electronic interactions between achiral inorganic frameworks and chiral ligands. These techniques collectively provide a toolkit for imparting chiroptical activity.

Several distinct synthetic strategies have been developed to impart chirality into perovskite architectures. The first is the  chiral ligand-induced strategy, which involves introducing suitable chiral organic molecules as the A-site cation; this method is regarded as relatively straightforward. A second approach induces chiral distortion of the perovskite surfaces through interaction with adsorbed chiral molecules. A third technique achieves enantiomer enrichment via chiral dislocations prompted by organic molecules. Finally, a fourth mechanism operates through chirality transfer, mediated by electronic interactions between inherently achiral inorganic frameworks and chiral ligand molecules [8]. These methods provide a versatile platform for engineering chiroptical properties.

This curated collection consolidates the fundamentals and recent advancements in chiral perovskite architectures, providing a foundational understanding for emerging technological platforms. This pioneering study, conducted by Zhao, et al. [9], investigated the development of bifunctional, water-stable chiral perovskite nanomaterials, Bio-(S/R- PEA)₂CsPb₂Br₇, for advanced biological applications. Synthesized via an improved ligand-assisted method and stabilized with mPEG-NH₂, these materials uniquely integrate chirality to biological specificity. Their dual functionality was demonstrated in two distinct realms: first, as highly sensitive fluorescent probes for aqueous H₂S detection, exhibiting rapid, visually detectable fluorescence quenching and a low detection limit. Second, leveraging their inherent positive surface charge, they served as potent antimicrobial agents, achieving exceptional inhibition rates over 97% against E. coli by disrupting bacterial membrane permeability. This work represents a significant breakthrough, marking the first application of organic-inorganic hybrid perovskites as versatile bifunctional tools that combine superior optical properties with inherent biocatalytic activity for imaging and antibacterial applications [10].

Similarly, Huang, et al. [5] used a low-temperature crystallization method to successfully synthesize a pair of enantiomeric single-crystalline perovskites, R- and S-(BrBA)₂PbBr₄. These two-dimensional chiral materials display notable structural distortion in their inorganic frameworks, driven by the integrated chiral organic cations. This structural feature provides a significant circular dichroism response and a photocurrent anisotropy factor of 0.14 at 405 nm. Along with a wide optical bandgap and a device design with vertical electrodes, these properties enable highly sensitive detection of circularly polarised ultraviolet light with minimal dark current. Additionally, the semiconductor demonstrates exceptional performance in X-ray detection, achieving a sensitivity of 531.33 μCGy⁻¹cm⁻² and an impressively low detection limit of below 100 nGys⁻¹, greatly surpassing the sensitivity required for medical imaging. Practical X-ray imaging tests confirm its strong potential for direct application in radiographic procedures.

References

  1. Cho NH, Kim H, Kim JW, Kim RM, Lee YH, et al. (2024) Chiral Inorganic Nanomaterials for Biomedical Applications. Chem 10(4): 1052-1070.
  2. Wang F, Yue X, Ding Q, Lin H, Xu C, et al. (2023) Chiral Inorganic Nanomaterials for Biological Applications. Nanoscale 15: 2541-2552.
  3. Revanakar SS, Jena S, Krishnaiah H, Rondiya SR (2025) Challenges, Solutions, and Opportunities in Chiral Perovskites: From Synthesis Strategies to Technological Advancements. Langmuir 41(29): 18935-18964
  4. Yang Z, Yao J, Xu L, Fan W, Song J (2024) Designer Bright and Fast CsPbBr3  Perovskite Nanocrystal Scintillators for High-speed X-ray Imaging. Nature Commun 15: 8870.
  5. Li M, Fang F, Huang X, Liu G, Lai Z, et al. (2022) Chiral Ligand-Induced Structural Transformation of Low- Dimensional Hybrid Perovskite for Circularly Polarized Photodetection. Chem Mater 34(7): 2955-2962.
  6. Dunlap-Shohl WA, Tabassum N, Zhang P, Shiby E, Beratan DN, et al. (2024) Electron-Donating Functional Groups Strengthen Ligand-Induced Chiral Imprinting on CsPbBr3 Quantum Dots. Sci Rep 14: 336.
  7. Zhong WH, Chen HR, Li ZM, Zhu JY, Shi CH, et al. (2023) 1D Chiral Enantiomer Lead-Free Perovskites Induced Chiral Optical Activity and Photoelectric Response. Inorg Chem 62(43): 17985-17992.
  8. Ma S, Jung YK, Ahn J, Kyhm J, Tan J, et al. (2022) Elucidating the Origin of Chiroptical Activity in Chiral 2D Perovskite through Nano-Confined Growth. Nature Commun 13: 3259.
  9. Zhang J, Yuan Z, Wang C, Liu L, Wang Y, et al. (2024) Aqueous-Phase Dual-Functional Chiral Perovskites for Hydrogen Sulfide (H2S) Detection and Antibacterial Applications in Escherichia Coli. J of Collide and Interface Science 661: 740-749.
  10. Gu Q, Chen K, Zhang X, Wang S, Wu S, et al. (2025) Butylammonium-Based Chiral 2D Perovskite Single Crystals for Efficient UV Circularly Polarized Light Differentiation and High-Performance X‑ray Detection. ACS Appl Mater Interfaces 17(11): 17127-17134.

Cite this article

BibTeX
APA
RIS
@article{gull2025,
  title   = {Solution-Processed Chiral Perovskites for Biomedical Applications},
  author  = {Gull S and Ullah F},
  journal = {Nanomedicine & Nanotechnology Open Access},
  year    = {2025},
  volume  = {10},
  number  = {4},
  doi     = {10.23880/nnoa-16000349}
}
Gull S and Ullah F (2025). Solution-Processed Chiral Perovskites for Biomedical Applications. Nanomedicine & Nanotechnology Open Access, 10(4). https://doi.org/10.23880/nnoa-16000349
TY  - JOUR
TI  - Solution-Processed Chiral Perovskites for Biomedical Applications
AU  - Gull S and Ullah F
JO  - Nanomedicine & Nanotechnology Open Access
PY  - 2025
VL  - 10
IS  - 4
DO  - 10.23880/nnoa-16000349
ER  -